ABSTRACT
Hibiscus sabdariffa Linn (Roselle) is an annual shrub commonly used to make jellies, jams,
beverages and used traditionally as a medicinal plant for the treatment of
various ailments. The present study was undertaken to investigate the effect of
aqueous extract of Hibiscus sabdariffa
calyx on male rat reproductive hormones. Twenty (20) male wistar rat weighing
0.25±0.2 kg were grouped into one water
control group and three experimental groups. While the water control group
received 1.0 ml of water for 28 days, the experimental group were administered
250 mg/kg oral doses of aqueous extract of H.sabdariffa
calyx. The effect on the basal levels of follicle stimulating hormone,
testosterone, prolactin, luteinizing hormone and estradiol were conducted in
experimental animals. The 28 days oral administration of aqueous extract of H.sabdariffa L. is associated with a
decreased circulating plasma levels of follicle stimulating hormone,
Testosterone and prolactin in male wistar rat compared with the control group.
The study did not show a change in the plasma levels of both circulating
luteinizing hormone and estradiol following 28 days oral administration of H.sabdariffa calyx to the experimental
animal. Moreover, Marked histological changes were detected on testes of the
experimental animals after 28 days of administration. This may indicate that H.sadariffa calyx extract can cause both
morphological and physiological testicular damage. The study concluded that H. sabdariffa calyx extract at a dose of
250 mg/kg caused mild effects on rat reproductive hormones.
TABLE OF CONTENT
CHAPTER ONE
1.0 INTRODUCTION
1.1 Literature
Review
1.1.1.
Botanical description
1.1.1.2.
Morphology
1.1.1.3 Ecology/cultivation
1.1.1.4.
Karyotype
1.1.2 Economic importance of Hibiscus sabdariffa
1.1.2.1.
Traditional culinary use
1.1.2.2.
Use in local and traditional food and medicine
1.1.2.3.
Source of fibre
1.1.2.4.
Animal feed
1.1.2.5.
Cosmetic
1.1.3.
Phytochemistry
1.1.3.1.
Nutritional value
1.1.3.2.
Bioactive constituents
1.1.3.3.
Organic acids
1.1.3.4.
Hydroxycitric acid
1.1.3.5.
Hibiscus acid
1.1.3.6.
Flavonoids
1.1.3.7.
Anthocyanins
1.1.3.8.
Mucilage, pectin and carbohydrates (polysaccharides)
1.1.3.9.
Volatile compounds
1.1.4
Biological and pharmacological activities
1.1.4a Effects on smooth muscles
1.1.4b
Antibacterial, antifungal and antiparasitic activity
1.1.4c.
Antipyretic, antinociceptic and anti-inflammatory activities
1.1.4d Antioxidant activity
1.1.4e
Hepatoprotective activity
1.1.4f
Nephroprotective activity
1.1.4gRenal
effects/diuretic effect (incl. clinical studies)
1.1.4h
Cancer-preventive activity
1.1.4i
Lipid metabolism – anticholesterol effects/effects on lipid metabolism
1.1.4j
Anti-obesity activity
1.1.4k
Lactating activity
1.1.4l
Anti-diabetic activity
1.1.4m
Delayed puberty activity
1.1.4n
Anti-hypertensive activity
1.1.4o
Anti-anaemic activity
1.1.5 Safety
1.1.6.
Toxicology
1.1.7.
Interactions
1.1.8.
Anatomy of the male rat testes
1.1.8.1.
Brief anatomy of the rat testes
1.1.8.2. Structure-Function relationship of the male rat testes
1.1.9. Reproductive hormones
1.1.9.1. Follicle stimulating hormone (FSH)
1.1.9.2. Luteinizing hormone (LH)
1.1.9.3. Testosterone
1.1.9.4.
Estradiol
1.1.9.5 Prolactin
CHAPTER
TWO
MATERIALS
AND METHODS
2.1 MATERIALS
2.1.1a Chemicals and scientific
kits.
2.1.1b List of Equipments
2.1.2 Plant Material
2.1.3 Experimental Animals
2.2 METHODS
2.2.1 Preparation of whole extract
of Hibiscus sabdariffa calyx
2.2.2 Experimental Design
2.2.4 Blood collection.
2.2.5 Histological Examination
2.2.5 Hormonal Assay
2.2.5.1 Assay for Reproductve
hormones
2.2.5.1a Assay for Plasma FSH and
LH
2.2.5.1b Principles of Assay
2.2.5.1c Assay Procedure
2.2.5.1d Calculation of FSH
Concentration
2.2.5.1e Calculation of LH
Concentration
2.2.5.2 Assay for Plasma Estradiol
2.2.5.2a Principle of the Assay
2.2.5.2b Assay Procedure
2.2.5.2c. Calculation of
Estradiol concentration
2.2.5.3 Assay for Testosterone
2.2.5.3a Principle of Assay
2.2.5.3b Assay Procedure
2.2.5.3c Calculation of
Testosterone Concentration
2.2.5.4a. Assay for Prolactin
2.2.5.4b. Principle of Assay
2.2.5.4b Assay Procedure
2.2.5.4c Calculation of prolactin
Concentration
2.2.6 Statistical Analysis
CHAPTER
THREE
3.0
RESULTS
3.2
Histological Examination of Male rat testes
3.2.1 Histological examination of rat testes of the control group.
3.2.2
Histological effect of H.sabdariffa
calyx extract on rat testes 0f H.sabdariffa
administered group. (Group 2)
CHAPTER FOUR
DISCUSSION
AND CONCCLUSION
CONCLUSION
REFERENCE
APPENDIX I
APPENDIX II
APPENDIX III
CHAPTER ONE
1.0
INTRODUCTION
Endocrine
disrupting compounds (EDCs) are natural or synthetic compounds that have the
ability within the body to alter endocrine functions often through mimicking or
blocking endogenous hormones (James et al.,
2013). These actions on the endocrine system have resulted in developmental
deficits in various invertebrate and aquatic species (Crain et al., 2007; Elango et al., 2006) and mammals (Christopher et al., 2012). Exposures in adulthood
have consequences but fetal and early life exposures appear to have more severe
effects that persist through life (Rubin and Soto, 2009). Among these classes
of chemicals are phytoestrogens that show effects suggestive of estrogenicity,
such as binding to the estrogen receptors, induction of specific
estrogen-responsive gene products, stimulation of estrogen receptor(s) and
positive breast cancer cell growth (James et
al., 2013). Through these interactions by acting as agonists or
antagonists, EDCs are able to alter the activity of response elements of genes,
block natural hormones from binding to their receptors, or in some cases
increase the perceived amount of endogenous hormone in the body by acting as a
hormone mimic to its receptor (Ze-hua et
al., 2010).
Hibiscus sabdariffa
Linn (Roselle) is an annual shrub commonly used to make jellies, jams and
beverages (Sirag et al., 2013). The
brilliant red colour of its calyx makes it a valuable food product, a part from
its multitude of traditional medicinal uses (Sirag et al., 2013). Infusions of the calyces are considered as diuretic,
cholerectic, febrifugal and hypotensive, decreasing the viscosity of the blood
and stimulating intestinal peristalsis (Salleh et al., 2002). Roselle calyx extract is a good source of
antioxidants from its anthocyanins and associated with antitumor and inhibitory
effects on the growth of several cancer cells (Ajiboye et al., 2011).
Extracts
of H.sabdariffa calyces have been
reported to be rich in phytoestrogens (Adigun et al., 2006; Orisakwe et al.,
2004; Brian et al., 2009; Omotuyi et al., 2011) and some reports indicated
that H.sabdariffa calyces have
estrogenic effects, although exact estrogen-like ingredient is not determined
(Ali et al., 1989).
This
study was undertaken to determine to which extent H.sabdariffa calyces extract alters the basal levels of selected
reproductive hormones: Follicle stimulating hormone, testosterone, prolactin,
estradiol, and luteinizing hormone as well as the histological features male
wistar rat testes.
1.2
Literature
Review
H.sabdariffa L.
Hibiscus sabdariffa
L. also known as roselle, is an ideal crop for developing countries as it is
relatively easy to grow, can be grown as part of multi-cropping systems and can
be used as food and fibre (Da-costa-Rocha et
al., 2014). In China the seeds are used for their oil and the plant is used
for its medicinal properties, while in West Africa the leaves and powdered
seeds are used in meals (Da-costa-Rocha et
al., 2014). Additionally, it is used in the pharmaceutical and food
industries (Da-costa-Rocha et al.,
2014).
A
limited number of reviews on H.sabdariffa
have been conducted. Only one detailed review on the phytochemical,
pharmacological and toxicological properties of H.sabdariffa ( Ali et al.,
2005) and two more focused, later reviews are available: One on the effectiveness
of H.sabdariffa in the treatment of
hypertension ( Wahabi et al., 2010)
and another on the treatment of hypertension and hyperlipidemia ( Hopkins et al., 2013).
1.1.1.
Botanical description
The
genus Hibiscus (Malvaceae) includes more than 300 species of annual or
perennial herbs, shrubs or trees (Wang et
al., 2012). H.sabdariffa (syn.: Abelmoschus cruentus (Bertol.) Walp., Furcaria sabdariffa Ulbr., Hibiscus
cruentus Bertol., Hibiscus fraternus
L., Hibiscus palmatilobus Baill.
and Sabdariffa rubra Kostel ( The
Plant list, 2010) is commonly known as roselle, hibiscus, Jamaica sorrel or red
sorrel (English) and in Arabic, karkadeh ( Ali et al., 2005 ; Ross, 2003). Its native distribution is uncertain,
some believe that is from India or Saudi Arabia ( Ismail, Ikram, and Nazri,
2008), while Murdock ( Murdock, 1959) showed evidence that H.sabdariffa was domesticated by the black populations of western
Sudan (Africa) sometime before 4000 BC. Nowadays, it is widely cultivated in
both tropical and subtropical regions (Morton, 1987 and USDA, 2007) including
India, Saudi Arabia, China, Malaysia, Indonesia, The Philippines, Vietnam, Sudan,
Egypt, Nigeria and México (Chewonarin et
al., 1999; Dung et al., 1999;
Eslaminejad and Zakaria, 2011; Ismail et
al., 2008; Mahran et al., 1979;
Rao, 1996; Sharaf, 1962 and Yagoub Ael et
al., 2004).
There
are two main varieties of H.sabdariffa,
the first being H.sabdariffa var.
altissima Wester, cultivated for its jute-like fibre and the second is H.sabdariffa var. sabdariffa. The second
variety includes shorter bushy forms, which have been described as races:
bhagalpuriensi, intermedius, albus and ruber. The first variety has green,
red-streaked, inedible calyces, while the second and third race have
yellow-green edible calyces (var. ruber) and also yield fibre (Morton, 1987).
1.1.1.2.
Morphology
H.sabdariffa
var. sabdariffa ruber is an annual, erect, bushy, herbaceous subshrub that can
grow up to 8 ft (2.4 m) tall, with smooth or nearly smooth, cylindrical,
typically red stems. The leaves are alternate, 3 to 5 in (7.5–12.5 cm) long,
green with reddish veins and long or short petioles. The leaves of young
seedlings and upper leaves of older plants are simple; lower leaves are deeply
3 to 5 or even 7 lobed; the margins are toothed. Flowers, borne singly in the
leaf axils, are up to 5 in (12.5 cm) wide, yellow or buff with a rose or maroon
eye, and turn pink as they wither at the end of the day. At this time, the
typically red calyx, consisting of 5 large sepals with a collar (epicalyx) of 8
to 12 slim, pointed bracts (or bracteoles) around the base, begins to enlarge,
becomes fleshy, crisp but juicy, 1 1/4 to 2 1/4 in (3.2–5.7 cm) long and fully
encloses the velvety capsule, 1/2 to 3/4 in (1.25–2 cm) long, which is green
when immature, 5-valved, with each valve containing 3 to 4 kidney-shaped,
light-brown seeds, 1/8 to 3/16 in (3–5 mm) long and minutely downy. The capsule
turns brown and splits open when mature and dry. The calyx, stems and leaves
are acid and closely resemble the cranberry (Vaccinium spp.) in flavour
(Morton, 1987; Ross, 2003).
Fig.1.
H.sabdariffa calyx
1.1.1.3 Ecology/cultivation
H.sabdariffa
is easy to grow in most well drained soils but can tolerate poor soils. It
requires 4-8 montH.sabdariffa growth
with night-time temperatures with a minimum of 20 °C, as well as 13 h of
sunlight and a monthly rainfall ranging from 5–10″ (130–250 mm) during the
first few montH.sabdariffa to prevent
premature flowering. Rain or high humidity during the harvest time and drying
process can downgrade the quality of the calyces and reduce the yield. The
quality of H.sabdariffa is determined
by seed stock, local growing conditions, time of harvest, post-harvest handling
and mainly the drying step. Most of the time it grows as a supplement crop and
it is susceptible to fungi, viral and bacterial attack and also to insects. A
single plant produces about 1.5 kg of fruit, approximately 8 t/ha. Yields of
leaves may be about 10 t/ha ( EcoCrop, 2007; Plotto, 2004).
1.1.1.4.
Karyotype
2n
= 36 (Huang et al., 1989; Menzel and
Wilson, 1961) and 72 (Chennaveeraiah and Subbarao, 1965; Wilson and Menzel,
1964) were observed. Somatic tissue showing diploid and tetraploid segments were
also occasionally noticed (Tjio, 1948). In a karyomorphological study conducted
in India, both root and flower segments showed great similarity in the types of
chromosomes in the complement. This indicates that the tetraploid tissue must
have arisen in an autotetraploid manner (Bhatt and Dasgupta, 1976). Later, this
species was reported to be tetraploid (2n = 72) (Hiron et al., 2006).
1.1.2 Economic
importance of Hibiscus sabdariffa
1.1.2.1. Traditional
culinary use
Fresh
or dried calyces of H.sabdariffa (cH.sabdariffa) are used in the
preparation of herbal drinks, hot and cold beverages, fermented drinks, wine,
jam, jellied confectionaries, ice cream, chocolates, flavouring agents, puddings
and cakes (Bako et al., 2009; Bolade et al., 2009; Esselen and Sammy, 1975;
Ismail et al., 2008; Okoro, 2007;
Plotto, 2004; Rao, 1996; Tsai et al.,
2002; Wilson and Menzel, 1964). In Egypt, the fleshy calyces are used in making
“cacody tea” and fermented drinks (Kochhar, 1986), while in Sudan and Nigeria,
the calyces are boiled with sugar to produce a drink known as “Karkade” or
“Zoborodo” (Gibbon and Pain, 1985). In Mexico this drink is called Jamaica or
“agua de Jamaica’” or “té de Jamaica”. In the West Indies the calyces can also
be used as colouring and flavouring ingredient in rum (Ismail et al., 2008).
The
seeds are eaten roasted or ground in meals, while the leaves and shoots are
eaten raw or cooked, or as a sour-flavoured vegetable or condiment (Wilson and
Menzel, 1964). In Sudan, the leaves are eaten green or dried, cooked with
onions and groundnuts, while in Malaysia the cooked leaves are eaten as vegetables
(Ismail et al., 2008). In Africa, the
seeds are roasted or ground into powder and used in meals, suh as oily soups
and sauces. In China and West Africa, the seeds are also used for their oil
(Atta and Imaizumi, 2002). Another use for the seed is as a substitute for
coffee (Morton, 1987).
1.1.2.2. Use in local
and traditional food and medicine
H.sabdariffa
has been widely used in local medicines. In India, Africa and Mexico, infusions
of the leaves or calyces are traditionally used for their diuretic,
cholerectic, febrifugal and hypotensive effects, decreasing the viscosity of
the blood and stimulating intestinal peristalsis. It is also recommended as a
hypotensive in Senegal (Morton, 1987). In Egypt, preparations from the calyces
have been used to treat cardiac and nerve diseases and also to increase the
production of urine (diuresis). In Egypt and Sudan, an infusion of “Karkade”
calyces is also used to help lower body temperature (Leung, 1996). In Guatemala
it is used for treating drunkenness (Morton, 1987). In North Africa, calyces
preparations are used to treat sore throats and cougH.sabdariffa, as well as genital problems, while the emollient leaf
pulp is used for treating external wounds and abscesses (Neuwinger, 2000). In
India, a decoction from the seeds is used to relieve pain in urination and
indigestion. In Brazil, the roots are believed to have stomachic and emollient
properties. In Chinese folk medicine, it is used to treat liver disorders and
high blood pressure (Morton, 1987). In Iran, sour hibiscus tea is reportedly a
traditional treatment for hypertension ( Burnham et al., 2002), while in Nigeria the decoction of the seeds is
traditionally used to enhance or induce lactation in cases of poor milk
production, poor letdown and maternal mortality ( Gaya et al., 2009).
1.1.2.3. Source of
fibre
H.sabdariffa
is one of the most important species grown commercially as a fibre plant and
became increasingly important in India after independence and partition with
Pakistan, where the most important jute (Corchorus
capsularis L. or Corchorus olitorius
L.) growing areas are. It is used as a jute substitute in making clothing,
linen, fishing nets, ropes and similar items (Clydesdale et al., 1979). Despite the fact that this species is slow growing,
as it requires about 180 days to produce a satisfactory yield of fibre, there
is still interest in the plant as some varieties of H.sabdariffa (not edible but fibre type) have a high degree of
genetic resistance to root-knot nematodes.
However,
H.sabdariffa fibres are subject to
ongoing research showing promising technical properties when used as a
substitute for synthetic or mineral fibres in composite materials, as well as a
source material for high quality paper production (Dutt et al., 2010; Kumar et al.,
2013; Singha and Kumar, 2008).
1.1.2.4. Animal feed
The
leaves are used for animal fodder and fibre (Plotto, 2004). The seeds can be
used to feed poultry as well as sheep and the residue from the seeds oil
extraction can also be used to feed cattle and chicks (Al-Wandawi et al., 1984; Elamin et al., 2012; Morton, 1987; Mukhtar,
2007).
1.1.2.5. Cosmetic
In
Malaysia the oil is used to produce scrubs and soaps (Ismail et al., 2008).
1.1.3. Phytochemistry
1.1.3.1. Nutritional
value
The
nutritional composition of fresh calyx of H.sabdariffa
varies between studies, probably due to different varieties, genetic,
environmental, ecology and harvest conditions of the plant. Early studies
reported that cH.sabdariffa contains
protein (1.9 g/100 g), fat (0.1 g/100 g), carbohydrates (12.3 g/100 g) and
fibre (2.3 g/100 g). They are rich in vitamin C (14 mg/100 g), β-carotene (300
μg/100 g), calcium (1.72 mg/100 g) and iron (57 mg/100 g) (Ismail et al., 2008).
The
leaves contain protein (3.3 g/100 g), fat (0.3 g/100 g), carbohydrate (9.2
g/100 g), minerals (phosphorus (214 mg/100 g), iron (4.8 mg/100 g) thiamine
(0.45 mg/100 g), β-carotene (4135 μg/100 g), riboflavin (0.45 mg/100 g) and
ascorbic acid (54 mg/100 g) (Ismail et al.,
2008).
The
seeds contained crude fatty oil (21.85%), crude protein (27.78%), carbohydrate
(21.25%), crude fibre (16.44%) and ash (6.2%). In terms of minerals, the most
prevalent is potassium (1329 ± 1.47 mg/100 g), followed by sodium (659 ± 1.58
mg/100 g), calcium (647 ± 1.21 mg/100 g), phosphorus (510 ± 1.58 mg/100 g) and
magnesium (442.8 ± 1.80 mg/100 g). The major saturated fatty acids identified
in the seed oil are palmitic (20.84%) and stearic (5.88%) acids and the main
unsaturated fatty acids are linoleic (39.31%) and oleic acid (32.06%) (Nzikou et al., 2011).
1.1.3.2. Bioactive
constituents
The
main constituents of H.sabdariffa
relevant in the context of its pharmacological are organic acids, anthocyanins,
polysaccharides and flavonoids (Eggensperger and Wilker, 1996; Müller and
Regensburg, 1990).
1.1.3.3. Organic acids
H.sabdariffa
extracts contain a high percentage of organic acids, including citric acid,
hydroxycitric acid, hibiscus acid, malic and tartaric acids as major compounds,
and oxalic and ascorbic acids as minor compounds (Da-costa-rocha et al., 2014).
Based on previous studies, the percentage of organic acids in “hibisci flos”
varies; hibiscus acid accounts for 13–24%, citric acid 12–20%, malic acid 2–9%,
tartaric acid 8% and 0.02–0.05% of ascorbic acid (vitamin C) (Eggensperger and
Wilker, 1996 and Schilcher, 1976).
In
the late 1930s, citric and malic acids were first reported in aqueous extracts
of the calyx (Buogo and Picchinenna, 1937, Indovina and Capotummino, 1938 and
Reaubourg and Monceaux, 1940) and also in five different strains (from Egypt,
Senegal, India, Thailand and Central America) of H.sabdariffa var. sabdariffa (Khafaga, Koch, El Afry, and Prinz,
1980). Ascorbic acid is also present in cH.sabdariffa
but its content varies dramatically between fresh (6.7–14 mg/100 g (Ismail et al., 2008; Morton, 1987)) and dried
calyces (260–280 mg/100 g (Ismail et al.,
2008)). The amount of ascorbic acid in the latter report being much higher than
the ones previously reported in the literature. The differences observed might
be due to different varieties, genetics, and environment, ecology and harvest
conditions.
1.1.3.4. Hydroxycitric
acid
(Fig.
2) has an additional hydroxyl group at the second carbon of citric acid. This
acid has four stereoisomers, (2S, 3S), (2R, 3R), (2S, 3R) and (2R, 3S), and
their lactone forms. The principal organic acid found in the cH.sabdariffa is the (2S, 3R)-hydroxycitric
acid (Hida et al., 2007). It is the
principal organic acid found in the calyces of H.sabdariffa. It is worth noting that, (2S, 3R)-hydroxycitric acid
from Hibiscus is different from the more commonly known (2S,3S)-hydroxycitric
acid (HCA) extracted from, e.g., Garcinia
sp., thus raising the question as to whether both diastereomers have identical
or partially different pharmacological profiles.
1.1.3.5. Hibiscus acid
(Fig.
2) is the lactone form of (+)-allo-hydroxycitric acid. It compromises a citric
acid moiety with an additional hydroxyl group at the second carbon and has two
diastereomers due to the existence of two chiral centers in the molecule (Boll et al., 1969; Eggensperger and Wilker, 1996;
Griebel and Lebensm, 1939; Griebel and Lebensm, 1942).
Hydroxycitric
acid, hibiscus acid and it derivatives as the major organic acids in the leaves
and calyces extracts of H.sabdariffa
( Beltran-Debon et al., 2010; Herranz-Lopez
et al., 2012; Peng et al., 2011;Ramirez-Rodrigues et al., 2011a; Ramirez-Rodrigues et al., 2011b ; Rodriguez-Medina et al., 2009).
Fig.2
citric acid and its derivatives
1.1.3.6. Flavonoids
H.sabdariffa
contains polyphenols of the flavonol and flavanol type in simple or polymerised
form. The following flavonoids have been described in H.sabdariffa extracts: hibiscitrin (hibiscetin-3-glucoside),
sabdaritrin, gossypitrin, gossytrin and other gossypetin glucosides, quercetin
and luteolin ( McKay, 2009; Williamson et
al., 2013); as well as chlorogenic acid, protocatechuic acid, pelargonidic
acid, eugenol, quercetin, luteolin and the sterols β-sitosterol and ergosterol
( McKay, 2009 ; Williamson et al.,
2013).
Earlier
the flowers of H.sabdariffa were
recorded to contain 3-monoglucoside of hibiscetin (hibiscitrin) (Rao and
Seshadri, 1942; Rao and Seshadri, 1942; Rao and Seshadri, 1948), 7-glucoside of
gossypetin (gossypitrin) and sabdaritrin, which on acid hydrolysis yielded an
hydroxyflavone named sabdaretin (Rao and Seshadri, 1942; Rao and Seshadri,
1942). The presence of these flavonol glycosides was low, with hibiscitrin
being the major compound followed by gossypitrin and sabdaritrin (Rao and
Seshadri, 1942; Rao and Seshadri, 1942). In 1961, gossypetin-3-glucoside (gossytrin)
was isolated (Seshadri and Thakur, 1961). The petals of H.sabdariffa var. altissima also contain gossypetin-8-glucoside
(0.4%) and gossypetin-7-glucoside (Subramanian and Nair, 1972).
From
the leaves of H.sabdariffa,
β-sitosteryl-β-d-galactoside (Osman et al.,
1975) and from the seeds ergosterol (Salama and Ibrahim, 1979) were reported.
β-sitosterol and ergosterol were also reported in H.sabdariffa extracts ( McKay, 2009; Williamson et al., 2013).
The
methanolic extract of the flowers also contains quercetin, luteolin and its
glycoside (Salah et al., 2002).
Quercetin had already been identified in H.sabdariffa
(Takeda and Yasui, 1985). One study reported that the amount of quercetin
present in cH.sabdariffa WE (calyces
of H.sabdariffa water extract) was
3.2 mg/g while rutin was 2.1 mg/g (Alarcon-Alonso et al., 2012). Quercetin and its conjugated glycosides
(quercetin-3-glucoside), as well as, rutin (quercetin-3-rutinoside; Fig. 3)
were frequently identified in cH.sabdariffa
WE, alongside with kaempferol ( Beltran-Debon et al., 2010; Herranz-Lopez et
al., 2012; Peng et al., 2011; Ramirez-Rodrigues
et al., 2011a ; Ramirez-Rodrigues et al., 2011b).
Fig.3.
Quercetin-3-rutinoside
1.1.3.7. Anthocyanins
The
anthocyanins are a group of flavonoid derivatives and natural pigments present
in the dried flowers of H.sabdariffa
and their colour varies with pH.
Delphinidin
and cyanidin-based anthocynins, include delphinidin-3-sambubioside (hibiscin),
cyanidin-3-sambubioside (gossypicyanin), cyanidin-3,5-diglucoside, delphinidin
(anthocyanidin) and others (Williamson et
al., 2009).
The
first anthocyanin from the calyx of H.sabdariffa
to be isolated was “hiviscin”, also known as “hibiscin”, later named
delphinidin-3-sambubioside and assigned the structure of cyanidin-3-glucoside
(Yamamoto and Osima, 1932), which was later renamed as delphinidin-pentoside-glucoside
(Yamamoto and Osima, 1936). From the pigments of cH.sabdariffa, three different anthocyanins were isolated:
delphinidin-3-sambubioside (hibiscin), delphinidin-3-glucoside and cyanidin-3-glucoside
(chrysanthenin) using material from Taiwan and Trinidad (Du and Francis, 1973;
Shibata et al., 1969). The last study
also identified cyanidin-3-sambubioside (gossypicyanin). Later, the presence of
cyanidin-3,5-diglucoside and cyanidin-3-(2G-glucosylrutinoside) in the flower
pigments of H.sabdariffa var.
altissima ( Subramanian and Nair, 1972) was reported. A study conducted with 5
different strains of H.sabdariffa
var. sabdariffa reported cyanidin-3-sambubioside and cyanidin-3-glucoside as
the major compounds present in this plant (khafaga et al., 1980). In one of the strains (Senegalese strain),
delphinidin glycosides were absent. In this study, the anthocyanin content
reached 1.7% to 2.5% of the dry weight in all strains. A similar anthocyanin
content was observed in another study where their amount was about 1.5 g per
100 g of dry weight of cH.sabdariffa,
in terms of delphinidin-3-sambubioside (Du and Francis, 1973).
Several
studies have identified delphinidin-3-sambubioside
(delphinidin-3-O-(2-O-β-d-xylopyranosyl)-β-d-glucopyranoise) and
cyanidin-3-sambubioside (cyanidin-3-O-(2-O-β-d-xylopyranosyl)-β-d- glucopyranoside) as the major
anthocyanins present in extracts from cH.sabdariffa
( Alarcon-Aguilar et al., 2007;
Alarcon-Alonso et al., 2012;
Beltran-Debon et al., 2010;
Degenhardt et al., 2000;
Herranz-Lopez et al., 2012; Peng et al., 2011) and leaves (
Rodriguez-Medina et al., 2009).
Fig.4.
Chemical structures of main anthocyanins
1.1.3.8. Mucilage,
pectin and carbohydrates (polysaccharides)
Polysaccharides
are another key group of compounds present in large quantities in the cH.sabdariffa WE (calyces of H.sabdariffa water extract). In one
study, the ethanol-precipitated water extract yielded 10% of reddish
polysaccharides. The following compounds were identified in two different
fractions, arabinose, galactose, glucose, rhamnose and smaller amounts of
galacturonic acid, glucuronic acid, manose and xylose ( Müller et al., 1989ss Similar results were
obtained in two other studies ( Brunold et
al., 2004; Müller and Franz, 1992).
The
mucilage content was determined in the calyces of five strains of H.sabdariffa var. sabdariffa, reaching
24–28% in strains from Central America and Egypt but only 15% in an Indian
strain. This amount was only reached at a later stage of development in the
strains from Senegal and Thailand. The pectin content only accounted for 2–4% while
the sugars reached a maximum of 3–5% in these five strains. Mucilage and pectin
consisted of 60–80% anhydrouronic acid (Afry et al., 1980).
The
petals of H.sabdariffa yielded 65% of
dry weight of mucilage, which on hydrolysis produced galactose, galacturonic
acid and rhamnose, while the leaves only yield 10% (El-Hamidi et al., 1967; Sengupta and Banik, 2011).
1.1.3.9. Volatile
compounds
Volatile
compounds are responsible for the aroma of H.sabdariffa.
In a study conducted in 1992, more than twenty-five volatile compounds
(accounting for less than 8% of total H.sabdariffa
seeds composition) were reported in seed oil of H.sabdariffa. They were mainly unsaturated hydrocarbons, alcohols and
aldehydes from C8 to C13. (Jirovetz et al.,
1992) Subsequently, thirty-seven volatile compounds from five different groups
from the cH.sabdariffa WE were
characterised. These compounds included fatty acid derivatives (such as
2-ethylfuran and hexanal), sugar derivatives (furfural and
5-methyl-2-furaldehyde), phenolic derivatives (eugenol), terpenes (such as
1,4-cineole, limonene) and miscellaneous compounds (e.g. acetic acid) (Chen et al., 1998). In another study, the
volatile profile was examined in four aqueous extracts from fresh and dried
calyx using two different, time–temperature extraction conditions by GC–MS. A
total of thirty-two compounds were identified and could be divided into five
chemical groups: aldehydes (fourteen compounds), alcohols (ten compounds),
ketones (five compounds), terpenes (two compounds) and acids (one compound) (Ramirez-Rodrigues
et al., 2011a; Ramirez-Rodrigues et al., 2011b). A total of seven
aromatic volatiles were common to all four samples tested (hexanal, 3-octanone,
octanal, 1-octen-3-one, nonanal, 2,4-nonadienal (E,E), and geranylacetone).
1.1.4 Biological and
pharmacological activities
A
detailed review of the pharmacological effects of H.sabdariffa extract is presented below.
1.1.4a Effects on smooth muscles
Early
studies showed that the alcoholic extract of H.sabdariffa flowers had an antispasmodic effect by relaxing the
uterus and intestine stips in vitro (Sharaf, 1962). This was also observed in
rabbit aortic smooth muscle (Obiefuna et
al., 1994). Interestingly, from various isolated muscle preparations, the
extract of H.sabdariffa inhibited the
tone of rabbit aortic strip, rhythmically contracting rat uterus, guinea-pig
tracheal chain and rat diaphragms, but it stimulated the tone of solated
quiescent rat uterus and frog rectus abdominis (Ali et al., 1991).
More
recently, the H.sabdariffa WE (1–100
mg/kg) was found to inhibit rat bladder and uterine contractibility in a dose
dependent manner, but via a mechanism unrelated to local or remote autonomic
receptors or calcium channels ( Fouda et
al., 2007) as previously suggested by Salah ( Salah et al., 2002).
Later,
it was shown that H.sabdariffa crude
extracts mainly induced the endothelium-dependent relaxant effect in the
isolated thoracic aorta of rats, via stimulation of NOS enzyme by the Pi3-K/Akt
pathway. It was suggested that this was due to polyphenols. The non-endothelium
dependent relaxation is a direct smooth muscle activation and results in the
activation of smooth muscle potassium channels (Sarr et al., 2009).
1.1.4b Antibacterial,
antifungal and antiparasitic activity
The
calyx of H.sabdariffa WE and
protocatechuic acid (5 mg/ml) inhibited the growth of methicillin-resistant
Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa and
Acinetobacter baumannii (Liu et al.,
2005). Moreover, protocatechuic acid (in a dose dependent manner) showed
greater antimicrobial activity against these pathogens in broth than in human
plasma. The study also revealed that the antibacterial effect was independent
from temperature, as shown by a heat treatment. Hibiscus extract also
demonstrated antibacterial effect against Streptococcus mutans, cariogenic
bacteria from the oral cavity, with a minimum inhibitory concentration of 2.5
mg/ml ( Afolabi et al., 2008) and Campylobacter species (Campylobacter jejuni, Campylobacter coli and Campylobacter fetus) that contaminates
meat like poultry, beef and pork at a concentration range of 96–152 μg/ml (Yin
and Chao, 2008). This time, the aqueous-methanol extract of dried cH.sabdariffa also showed an in vitro
inhibitory effect against several bacterial strains, such as S. aureus, Bacillus stearothermophilus, Micrococcus
luteus, Serratia mascences, Clostridium sporogenes, Escherichia coli, K. pneumonia, Bacillus cereus
and Pseudomonas fluorescence, but did
not effect the growth of fungus Candida
albicans (Olaleye, 2007). The fresh cH.sabdariffa
WE, ethanol extract and protocatechuic acid (20 mg/ml) was effective in
inhibiting the growth of food spoilage bacteria such as Salmonella typhimurium DT104, E.
coliO157:H7, Listeria monocytogenes,
S. aureus and B. cereus. Again the antibacterial effect was not affected by heat
treatment and the ethanolic extract showed greater antimicrobial effect than
the aqueous extract. The study further suggests that both, ethanolic extract and
protocatechuic acid, might be potent agents for use as food additives to
prevent contamination from these bacteria (Chao and Yin, 2009; Yin and Chao,
2008).
A
methanol-water extract of H.sabdariffa
was effective against E. coli O157:H7
isolates from food, veterinary and clinical samples (Fullerton et al., 2011), with the highest
concentration (10%) being the most effective.
The
crude extracts of H.sabdariffa seeds
(200 mg/l) also showed antimicrobial effect against three types of
Gram-negative bacteria. The extract exhibited higher activity against
Salmonella followed by Shigella and Enterobacter (Nwaiwu et al., 2012).
1.1.4c. Antipyretic,
antinociceptic and anti-inflammatory activities
Despite
the claims that H.sabdariffa is
effective in the relief of pyrexia in popular medicines, limited studies are
available. The antipyretic and anti-inflammatory potential of the cH.sabdariffa extract were studied in
vivo. The ethanol (more potent) and aqueous extracts showed antipyretic effects
by significantly reversing yeast-induced fever in rats. The mechanism is
different from the one of aspirin, a prostaglandin inhibitor. Nevertheless,
fever entails enhanced formation of cytokines such as interleukins (IL),
interferons and tumour necrosis factor-α (TNF-α). The cH.sabdariffa extract may be involved in the inhibition of some of
these substances, resulting also in an anti-inflammatory effect (Reanmongkol
and Itharat, 2007). Similar results were obtained by Dafallah (Dafallah and
al-Mustafa, 1996), suggesting that the flavonoids, polysaccharides and organic
acids might be the compounds responsible for the pharmacological activity. In a
more recent study the ethanolic extract from the calyces also showed
antinociceptive effect in a rat model (Ali et
al., 2011).
Another
in vivo study showed that the two fractions of the crude aqueous-ethanolic
extract of the dried cH.sabdariffa
exhibited impressive immunostimulatory activity by increasing the production of
IL-10 and decreasing the production of TNF-α (Fakeye, 2008). Another mechanism
in which the polyphenol extract exhibit its anti-inflammatory activity is by
impairing cyclooxygenase-2 induction by down-regulating JNK and p38 MAPK (Kao et al., 2009).
1.1.4d Antioxidant activity
Several
studies both in vitro (Duh and Yen, 1997; Farombi and Fakoya, 2005; Hirunpanich
et al., 2005; Mohd-Esa et al., 2010; Sayago-Ayerdi et al., 2007; Steenkamp et al., 2004; Tseng et al., 1997) and in vivo (Farombi and Fakoya, 2005; Mossalam et al., 2011; Olalye and Rocha, 2007;
Usoh et al., 2005) have shown that
extracts of H.sabdariffa have a
potent antioxidant effect.
The
antioxidant activity of the extract is due to its strong scavenging effect on
reactive oxygen and free radicals (Farombi and Fakoya, 2005; Mohd-Esa et al., 2010; Olalye and Rocha, 2007;
Sayago-Ayerdi et al., 2007;Tseng et al., 1997; Usoh et al., 2005), inhibition of xanthine oxidase activity, protective
action against tert-butyl hydroperoxide (t-BHP)-induced oxidative damage (
Tseng et al., 1997), protection of
cell from damage by lipid peroxidation ( Duh and Yen, 1997; Farombi and Fakoya,
2005; Olalye and Rocha, 2007), inhibition in Cu2+-mediated oxidation
of LDL and the formation of thiobarbituric acid reactive substances (TBARs) (
Hirunpanich et al., 2005; Ochani and
D’Mello, 2009; Olalye and Rocha, 2007), inhibition of the formation of
malondialdehyde content (100–300 mg/kg) ( Farombi and Fakoya, 2005; Usoh et al., 2005), reduction of glutathione
depletion, increase of the liver and decrease blood activity of superoxide
dismutase and catalase ( Usoh et al.,
2005) while in the liver it increased superoxide dismutase, catalase and
glutathione and decreased malondialdehyde ( Mossalam et al., 2011). The effects were observed for both water and
ethanolic extracts from flowers of H.sabdariffa,
as well as from the seeds or leaves (Mohd-Esa et al., 2010).
1.1.4e Hepatoprotective
activity
cH.sabdariffa WE (100–800 mg/kg) showed
hepatoprotective effects in a range of models based on toxin-induced hepatitis
including, tert-butylhydroperoxide, lipopolysaccharides, azathioprine, carbon
tetrachloride, cadmium, ammonium chloride, acetaminophen and irradiation in
vivo ( Adaramoye et al., 2008;
Ajiboye et al., 2011; Ali et al., 2003; Amin and Hamza, 2005;
Asagba et al., 2007; Essa et al., 2006; Lin et al., 2003; Liuet al.,
2002; Liu et al., 2010; Liu et al., 2006; Olaleye and Rocha, 2008;
Tseng et al., 1996; Wang et al., 2000) and in vitro ( Ajiboye et al., 2011; Lee et al., 2012; Yin et al.,
2011).
This
effect is due to a strong antioxidant activity, which reduces cellular damage
by reducing oxidative stress and by attenuating mitochondrial dysfunction
through decreasing Bax and tBid expression in the liver (Lee et al., 2012). The extract also
increased the activity of superoxide dismutase (SOD), catalase (CAT),
gluthathione peroxidase (GPx), and d-aminolevulinate dehydratase (d-ALA-D)
enzymes while decreasing lipid peroxidation in induced models of liver damage (Adaramoye
et al., 2008; Ajiboye et al., 2011; Olaleye and Rocha, 2008),
and decreased liver marker enzymes such as aspartate transaminase (AST),
alanine transaminase (ALT) and alkaline phosphatase (ALP) in experimental
hyperammonemia ( Essa et al., 2006).
An Hibiscus anthocyanin extract also induced phase II drug-detoxifying enzymes,
such as glutathione S-transferase, NAD(H):quinone oxidoreductase, and uridyl
diphosphoglucuronosyl transferase in an induced liver damage model (CCl4-mediated
toxicity model) ( Ajiboye et al.,
2011).
The
anthocyanins present in the extract seem to be the ones responsible for this
effect (Ajiboye et al., 2011; Ali et al., 2003; Wang et al., 2000). Another compound that has been identified to have
this effect was protocatechuic acid, a phenolic compound present in the H.sabdariffa extract ( Lin et al., 2003; Liu et al., 2002; Tseng et al.,
1996).
1.1.4f Nephroprotective
activity
Two
studies were reported on the nephroprotective activity of H.sabdariffa extracts on diabetic nephropathy in
streptozotocin-induced type 1 diabetic rats (Lee et al., 2009; Wang et al.,
2011). Nephropathy may progress to end-stage renal disease. A study was
conducted to investigate the effect of the polyphenol extract of H.sabdariffa (100 and 200 mg/kg/day) in
streptozotocin-induced diabetic nephropathy in rats. The extract revealed
beneficial effects as the kidney mass was reduced and the hydropic change of
renal proximal convoluted tubules was improved, it reduced serum triglyceride,
total cholesterol and LDL as well as increased the activity of catalase and
glutathione and reduced lipid peroxidation in the kidney (Lee et al., 2009). It was found that the
extracts reduced kidney mass and improved hydropic change of renal proximal
convoluted tubules in this rat model. The positive effect shown by the extracts
might be via improving oxidative status and regulating Akt/Bad/14-3-3γ
signalling (anti-apoptotic mechanisms). Another in vivo study also revealed
that its nephroprotective effect is a result of the protection of the kidney
from the oxidative stressed (Mossalam et
al., 2011).
1.1.4gRenal
effects/diuretic effect (incl. clinical studies)
The
renal effect of H.sabdariffa has been
characterised pharmacologically both in clinical trials (Herrera-Arellano et al., 2004; Kirdpon et al., 1994; Prasongwatana et al., 2008) and in pre-clinical
experiments in rats (Aguwa et al.,
2004; Laikangbam and Damayanti Devi, 2012).
A
two-phase study in Thailand with thirty-six healthy men was conducted to
evaluate the changes in urine after consumption of H.sabdariffa juice (16 g/day and 24 g/day) to determine its effect
on the treatment and prevention of renal stones. Despite the fact that the
consumption of H.sabdariffa caused a
decrease in creatinine, uric acid, citrate, tartrate, calcium, sodium,
potassium and phosphate it did not affect the concentration of oxalate in
urinary excretion. The authors suggested that there was no beneficial effect in
preventing renal stone formation and that long term and higher doses should be
investigated (Kirdpon et al., 1994).
Another intervention study carried out in Thailand with eighteen subjects with
or without history of renal stones revealed that H.sabdariffa tea drinking, at a dose of 3 g/day for 15 days, did
not show evidence for antilithiatic or diuretic effects. No significant
difference in serum sodium and urinary volume were observed during this study.
However, H.sabdariffa tea consumption
produced a uricosuric effect (Prasongwatana et
al., 2008). Similar results were observed in albino rats when given a
decoction of dried calyces at an oral dose of 1 g/kg (Caceres et al., 1987).
However,
in vivo an antilithiatic effect was observed. In Wistar rats, which were given
extract of H.sabdariffa orally at a
dose of 3.5 mg daily, the oxalate retention in the kidney decreased with
increased excretion into urine and decreased calcium crystal deposition in the
kidneys (Woottisin et al., 2011). The
cH.sabdariffa WE (250, 500 and 750
mg/kg body weight) also effectively prevented the development of urolithiasis
(stone-disorder) in male albino rats (Laikangbam et al., 2012). A decrease in renal Ca2+ andMg2+ATPase
activity and unaltered renal calcium handling in rats after administration of cH.sabdariffa WE at 25 and 50 mg/kg was
shown. Renal function was also enhanced by reduction of serum urea and
creatinine concentrations (Olatunji et al.,
2012). In another pre-clinical study in rats, cH.sabdariffa WE produced diuretic and natriuretic effects at the
dose range of 500 to 2500 mg/kg b.w. with a potassium-sparing effect (Alarcon-Alonso
et al., 2012). This diuretic effect
is in accordance with previous studies in experimental animals (Aguwa et al., 2004; Caceres et al., 1987; Onyenekwe et al., 1999; Ribeiro Rde et al., 1988) and one clinical trial (Herrera-Arellanoet al., 2004). In this single clinical
trial, assessing a chemically characterised extract of H.sabdariffa (9.6 mg of total anthocyanins) in patients with mild
to moderate hypertension, the treatment demonstrated a natriuretic effect with
no effects on chloride, potassium and pH ( Herrera-Arellano et al., 2004).
1.1.4h
Cancer-preventive activity
H.sabdariffa
is rich in phenolic compounds, such as protocatechuic acid. This compound
demonstrated in vitro protective effects against cytotoxicity and genotoxicity
of hepatocytes induced by tert-butylhydroperoxide (t-BHP), through inhibiting
action on DNA repair synthesis caused by t-BHP and by showing radical quenching
effect (Tseng et al., 1996). It also
inhibited 12-O-tetradecanolyphorbol-13-acetate (TPA)-induced skin tumour
formation in CD1-mice (Tseng et al.,
1998) and inhibited the survival of human promyelocytic leukaemia HL-60 cells (Tseng
et al., 2000). The mechanism by which
it exerted anticancer properties might be through antitumour promotion by
reducing reactive oxygen species (ROS), DNA fragmentation, G1 arrest and
apoptosis. The apoptosis-inducing activity was associated with the
phosphorylation and degradation of RB and the suppression of Bcl-2 protein.
Similar effects were observed in human gastric carcinoma (AGS) cells in which
the apoptotic effect may be mediated via p53 signaling and p38 MAPK/FasL cascade
pathway (Lin et al., 2005). Another
group of compounds present in cH.sabdariffa
extracts are anthocyanins such as delphinidin-3-sambubioside. They induced
apoptosis against human leukaemia cells ( Chang et al., 2005; Hou et al.,
2005) via the p38-FasL and Bid pathway and ROS-mediated mitochondrial
dysfunction pathway and against smooth muscle cells (SMC) via p38 and p53
pathway ( Lo et al., 2007).
Recently,
the anti-cancer activity of H.sabdariffa
leaf extracts were assessed against human prostate cancer cells in vitro and in
vivo (Lin et al., 2012). The study
showed the anti-apoptotic effect to be mediated via both intrinsic
(Bax/cytochrome c-mediated caspase 9) and extrinsic (Fas-mediated caspase
8/t-Bid) pathways, as well as by inhibiting the growth of prostate tumour
xenograft in athymic nude mice. The extract from leaves instead of calyces
represented a possible source of greater polyphenolic compounds.
1.1.4i Lipid metabolism
– anticholesterol effects/effects on lipid metabolism
Several
studies have showed that extracts of H.sabdariffa
have a lipid lowering activity, which could prevent diseases like
hyperlipidemia and cardiovascular diseases (atherosclerosis and coronary heart
disease) (Carvajal-Zarrabal et al.,
2005;Chang et al., 2006; Chen et al., 2003; Chen et al., 2004; el-Saadany et
al., 1991; Gosain et al., 2010;
Hirunpanich et al., 2006; Ochani and
D’Mello, 2009; Yang et al., 2010).
The
extracts (water and ethanolic extracts of dried calyces or leaves) were able to
decrease low-density lipoprotein cholesterol (LDL-c), triglycerides (TAG),
total cholesterol (TC) and lipid peroxidaxion in vivo. A few of them even
reported that the extract was also able to reduce very-low density lipoprotein
cholesterol (VLDL-c) (Farombi and Ige, 2007; Ochani and D’Mello, 2009) along
with an increase in serum level of high density lipoprotein cholesterol (HDL-c)
levels (Ochani and D’Mello, 2009; Yang et
al., 2010). Additionally, it also reduced foam cell formation and inhibited
smooth muscle cell migration and calcification in blood vessels of treated
rabbits. A possible explanation for the decrease in LDL-c could be related to
the inhibition of the triacylglycerol synthesis or other hypolipidemic effects,
through the antioxidant activity against LDL-c oxidation and hepatic liver
clearance. Several groups of compounds in the extract, such as anthocyanins and
protocatechuic acid, have been implicated as responsible for these effects
(Chang et al., 2006; Lee et al., 2012; Tseng et al., 1997).
1.1.4j Anti-obesity
activity
Pre-clinical
data from Brazil indicates a potential role in the control of certain
conditions associated with obesity, such as hyperlipidemia. However, further
studies were suggested (Dickel et al.,
2007).
A
report showed that a standardised (33.64 mg of total anthocyanins per each 120
mg) water extract of cH.sabdariffa
was able to reduce weight gain in obese mice while at the same time it increase
the liquid intake in healthy and obese mice (Alarcon-Aguilar et al., 2007). This effect is probably
achieved through the modulation of PI3-K/Akt and ERK pathway, which play pivotal
roles during adipogenesis (Kim et al.,
2007).
In
vitro and in vivo studies showed that Hibiscus extract (or tea) inhibited the
activity of α-amylase, blocking sugars and starch absorption, which may assist
in weight loss (Hansawasdi et al.,
2000; Hansawasdi et al., 2001; Preuss
et al., 2007). A study conducted in
Mexico using an ethanol extract of H.sabdariffa
concluded the extract could be considered as a possible anti-obesity agent due
to its effects on fat absorption-excretion and body weight of rats (Carvajal-Zarrabal
et al., 2009).
The
therapeutic use of the extract, possibly due to polyphenols, was also evaluated
in patients with metabolic syndrome, an obesity-associated collection of
disorders (Perez-Torres et al., 2012).
Meanwhile a study showed that the aqueous extract was more efficient in
inhibiting triglyceride accumulation when devoid of fibre and polysaccharides,
but when polyphenols were fractionated and isolated, the benefits of the whole
extract was greater than the sum of its parts (Herranz-Lopez et al., 2012).
1.1.4k Lactating
activity
The
ethanolic seed extract of H.sabdariffa
(200–1600 mg/kg) increased the serum prolactin level (p < 0.01) when
compared to the control in a dose-dependent manner in lactating Albino Wistar
rats (Gaya et al., 2009).
1.1.4l Anti-diabetic
activity
Diabetes
mellitus can be defined as an endocrine and metabolic disorder characterised by
chronic hyperglycaemia, dyslipidemia, and protein metabolism that results from
defects in both regulations of insulin secretion and/or insulin action.
The
protective effect of a polyphenol extract of H.sabdariffa was studied in a type II diabetic rat model (high fat
diet model). At a dose of 200 mg/kg, the extract demonstrated anti-insulin
resistance properties as it reduced hyperglycaemia and hyperinsulinemia. It
decreased serum triacylglycerol, cholesterol and the ratio of low-density
lipoprotein/high-density protein (LDL/HDL), as well as reduced the plasma
advanced glycation end products (AGE) formation and lipid peroxidation (Peng et al., 2011).
The
currently accepted therapeutic strategy for the control of postprandial
hyperglycaemia is based on the inhibition of α-glucosidase and α-amylase. This
results in an aggressive delay of carbohydrate digestion to absorbable
monosaccharide. With this in mind, a study was conducted to determine the
effect of H.sabdariffa extract on
intestinal α-glucosidase and pancreatic α-amylase activity in vitro. As a
result, H.sabdariffa extract was
shown to be a potent pancreatic α-amylase inhibitor (Adisakwattana et al., 2012). Similar results were
found for hibiscus acid (hibiscus-type (2S,3R)-hydroxycitric acid lactone) (Yamada
et al., 2007), which inhibited
pancreatic α-amylase and intestinal α-glucosidase enzyme (Hansawasdi et al., 2000; Hansawasdi et al., 2001).
Diabetes
mellitus is a risk factor for coronary heart diseases as well as
atherosclerosis. An ethnobotanical study conducted in the Caribbean for urinary
problems and diabetes mellitus revealed that H.sabdariffa is traditionally used to ‘clean’ the liver and blood
within a group of plants used for “cooling”, high cholesterol and urinary
problems. When the respondents were asked which medicinal plants were used for
high blood pressure, diabetes and jaundice, H.sabdariffa
was referred to hypertension (Lans, 2006). A study in alloxan-induced diabetic
rats showed that an ethanolic extract of H.sabdariffa
flowers (200 mg/kg) had a strong hypolipidemic as well as antioxidant effect.
Thus, H.sabdariffa extract showed
therapeutic promise in decreasing and preventing the development of
atherosclerosis and possible related cardiovascular pathologies linked with
diabetes. The authors suggest that this activity might be linked to
polyphenolic compounds and dihydrobenzoic acids, like protocatechuic acids, but
further identification of the active compounds is warranted (Farombi and Ige,
2007). A similar effect was reported (Huang et
al., 2009) with the extract suppressing the high-glucose-induced migration
in a vascular smooth muscle cell model.
1.1.4m Delayed puberty
activity
A
few studies with rats have shown that consumption of H.sabdariffa WE during pregnancy and lactation resulted in
increased postnatal weight gain, delayed onset of puberty and elevated body
mass index at onset of puberty in the female offsprings (Iyare and Adegoke,
2008a; Iyare and Adegoke, 2008b; Iyare and Adegoke, 2008c; Iyare and Nwagha,
2009). The consumption of the extract during pregnancy and lactation caused
decrease of maternal fluid and food intake with increased plasma Na+
and corticosterone concentration, while the accelerated growth and delayed
puberty observed in the offspring could be due to increased corticosterone and
decreased leptin delivery through breast milk (Iyare and Adegoke, 2008b; Iyare et al., 2010). These studies however
require confirmation as no observations have been reported in the literature up
to-date pointing to the presence of respective effects in humans.
1.1.4n
Anti-hypertensive activity
Decoctions
of H.sabdariffa have been used
traditionally in West Africa and Mexico as an anti-hypertensive remedy. Several
in vitro (Jonadet et al., 1990;Obiefuna
et al., 1994) and in vivo studies
have shown that the extract of the calyces (ranging from 125 to 500 mg/kg)
indeed reduce both the systolic and diastolic pressures, lowering heart rate
and working as a vasodilator (Adegunloye et
al., 1996; Ajay et al., 2007;
Inuwa et al., 2012; Mojiminiyi et al., 2007; Onyenekwe et al., 1999;Shehata and El Menoufy,
2008). The anti-hypertensive activity might be through: inhibition of
angiotensin-converting enzymes (ACE) ( Jonadet et al., 1990; Ojeda et al.,
2010), acetylcholine-like and histamine-like mechanisms ( Adegunloye et al., 1996), diuretic effect (
Mojiminiyi et al., 2000), reduction
in the diffusion distance between capillaries and myocytes, as well as new
vessel formation (Inuwa et al., 2012)
and direct vaso-relaxant effects ( Adegunloye et al., 1996; Ajay et al.,
2007; Obiefuna et al., 1994;
Adegunloye et al., 1994). The
relaxant effect might be partially endothelium independent and possibly
mediated by endothelium-derived nitric oxide (EDNO)-dependent action.
Endothelium-dependent vasodilator component results through activation of the
endothelium-derived nitric oxide/cGMP-relaxant pathway, whereas the
endothelium-independent component could be due to inhibition of Ca2+
influx (Ajay et al., 2007).
Additionally,
H.sabdariffa showed antiplatelet but
no thrombolytic activity in vitro (Yamamoto et
al., 2005). One in vivo study reported that despite the beneficial effect
as an anti-hypertensive, H.sabdariffa
might produce undesirable effects on gonadal activity (Shehata and El Menoufy,
2008).
1.1.4o Anti-anaemic
activity
A
preliminary study on the use of H.sabdariffa
decoctions as an alternative source of iron for the treatment of anaemia and
some other mineral deficiency diseases was conducted and showed that dry
fermented calyces of hibiscus exhibited a very low pH value which enhanced
mineral availability. Another reason for enhancing mineral (iron, zinc, calcium
and magnesium) bioavailability is the high concentration of ascorbic acid (Falade
et al., 2005).
The
effect of cH.sabdariffa extract (200
to 1000 mg/kg body weight) on some haematological parameters in rats was
studied to determine its medicinal usefulness in the treatment of anaemia. The
study suggested that at a comparatively high dose range of 200 to 400 mg/kg,
the extract had a beneficial effect on the red cells, but this was not sustained
at even higher doses (Adigun et al.,
2006). Another study using a rat model of infection with Trypanosoma congolense showed that the use of H.sabdariffa WE (equivalent to 9.61 mg/100 g/day of ascorbic acid
for 3 weeks) prevented the disease-induced anomalies with increase of serum
creatinine and urea levels. It was concluded that consumption of the extract
ameliorated the pathological changes in blood as well as hepatic and renal
structures of T. congolense-infected
rats. The observed effects might be due to the ascorbic acid component or other
antioxidants present, which presumably kept the free radical load in infected
rats low as well as preventing the disease-associated depletion in systemic
antioxidants. Nevertheless, further studies are needed to determine the
long-term effects and the mechanism of action before recommendations could be
made (Umar et al., 2009).
1.1.5 Safety
H.sabdariffa
preparations, predominantly the infusion and aqueous extracts, have a long
standing traditional use both in food and in medicine, and in general are
considered to be safe. The available toxicological data, however limited, are
in support of this assessment. The literature search for this review did not
reveal any case reports of adverse reactions following oral consumption of H.sabdariffa preparations.
1.1.6. Toxicology
In
a bioassay for screening plant extracts for their biological activity, the
lethal dose (LD50) of three different types of H.sabdariffa extract was assessed in the brine shrimp toxicity
assay. Aqueous H.sabdariffa extract
(i.e., infusion) produced an LD50 of 9.59 μg/ml, while for the
dichloromethane extract it was 24.51 μg/ml and 4.75 μg/ml for the ethanolic extract
(Serrano et al., 1996). Given the
very limited value of the brine shrimp assay for complex mixtures like plant
extracts (Manilal et al., 2009) and
the incomplete information on the mode of preparation of the extracts, this
work is mentioned here for completeness only.
The
LD50 in mice (b.w. 30 g) was reported to be about 0.4–0.6 ml on
intraperitoneal administration of a 30% aqueous H.sabdariffa decoction (20 min in distilled water) ( Sharaf, 1962).
The same authors observed a lowered blood pressure in dogs (b.w.: 7 kg) with no
side effects after administering (i.p.) 10 ml of a 10% solution of the H.sabdariffa decotion.
According
to a study of Onyenekwe and coauthors, no deatH.sabdariffa were observed in Albino mice after fourteen day’s
administration (i.p.) at doses of 1000–5000 mg/kg b.w./d., thus the calculated
LD50 of cH.sabdariffa
aqueous extract was >5000 mg/kg b.w. The same authors assessed the effect of
the extract on blood pressure in spontaneously hypertensive and normotensive
Wistar-Kyoto rats. As part of this study it was observed that between the
seventh and the twenty-first day after extract administration, the highest dose
of 1000 mg/kg resulted in spontaneous deatH.sabdariffa
in hypertensive but not in normotensive rats. With reference to the well known
increased risk of sudden cardiac death in patients receiving non-potassium
sparing diuretics, the authors speculate that the death of the animals may have
been due to a diuretic effect of the extract (Onyenekwe et al., 1999), however, the dose found to be active is excessively
high. Although Kirdpon and co-authors report a decrease of potassium and sodium
in 36 healthy young men after successive administration of 16 g/d Hibiscus
“Juice” (while surprisingly no such effect was seen in the high dose group with
24 g/d), this interpretation remains questionable in view of a much larger and
well-documented controlled clinical study in which Hibiscus extract showed a
natriuretic effect with no effects on chloride, potassium and pH in 171 men
with mild to moderate hypertension (Herrera-Arellano et al., 2004). Lack of acute toxicity with calculated LD50 values
>5000 mg/kg b.w. was reported for a methanolic dried flower extract in adult
albino mice on a herb-drug interaction study after 24 h administration (i.p.)
(Ndu et al., 2011) and for an
ethanolic extract of H.sabdariffa
seed in albino Wistar rats while studying the effect of the extract on
lactogenic activity (Gaya et al.,
2009).
Administration
of the water-soluble fraction of a concentrated cH.sabdariffa extract (extraction solvent: Methanol 80%) given
orally at up to 15 successive doses of 250 mg/kg/d to Wistar albino rats showed
no pathological features in both liver and heart after 24 h (Akindahunsi and
Olaleye, 2003). The authors observed a dose-related increase in the levels of
serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) when
compared to the control group. However, levels of the same enzymes decreased slightly
in the liver. In view of the extraordinarily high serum AST value in the
control group as compared to reference values from the literature (Boehm et al., 2007), the conclusions of the
authors regarding a putative cardio- or liver toxicity of the tested extract
have to be read with caution.
In
recent years the effect of Hibiscus extracts on reproduction and development in
rats has been subject to in vivo studies by several authors. In female rats,
addition of hibiscus extracts to drinking water resulted in a dose-dependent
reduction of fluid and feed intake. The effects observed in the pups included
increased weight gain and delayed onset of puberty. As the authors rightly
state, these effects have likely been caused by the reduced fluid and feed intake
in accordance with earlier publications. Rather than representing specific
toxicologic properties of hibiscus, the decreased fluid and feed intake and
subsequent adverse effects observed in this study may be the result of the
animals dislike for the flavour of hibiscus ( Iyare and Adegoke, 2008a; Iyare
and Adegoke, 2008b; Iyare et al.,
2010). Despite the fact that earlier studies showed the LD50 to be
above 5000 mg/kg and doses as high as 4600 mg/kg were administered to rats in
drinking water for 12 weeks with no increase in mortality, the extract induced
testicular toxicity (reduced sperm counts and spermatogenesis with evidence of
marked degenerative histological changes) at all concentrations tested
(1150–4600 mg/kg) (Orisakwe et al.,
2004). Additionally, deleterious effects on the testis and spermatozoa and an
adverse influence in the male reproductive fertility of albino mice were also
reported after a cH.sabdariffa WE was
administered daily for 4 weeks in a dose of 200 mg/kg (Mahmoud, 2012). In contrast
to these studies, long term administration of H.sabdariffa WE for 10 weeks and hibiscus anthocyanins (50–200
mg/kg b.w.) for 5 days did not affect the male reproductive system in rats (Ali
et al., 2012).
Fakeye
and co-authors assessed toxicological effects of a 90-day oral administration
of aqueous, ethanol or 50% ethanol extracts of dried cH.sabdariffa at doses of 300 and 2000 mg/kg b.w., respectively, in
male Charles Foster rats. Strikingly contrasting with previous studies by
various other authors, they observed a strong toxicity with total mortality in
all 2000 mg groups until day 28, and in the aqueous and 50% ethanol groups at
300 mg, until day 60 and 40, respectively. (Fakeye et al., 2009). At a dose of 300 mg/kg (b.w.) all extract types
produced a significant increase of plasma creatinine after 30 days
administration of the extracts. High creatinine blood levels may be associated
with muscular dystrophy, loss of kidney function or even mortality. However,
since the ethanol extract produced the strongest increase in creatinine but no
mortality at the 300 mg dose level, it is unlikely that the elevated creatinine
levels have been the cause of death in the other groups (Fakeye et al., 2009). Overall, the results of
this study remain highly questionable. The possible reasons considered by the
authors, including differences in anthocyanin content, are not convincing in
view of the still moderate anthocyanin doses provided with the extracts.
A
similar effect was observed on rat testis in a cisplatin (CIS)-induced rodent
model of reproductive toxicity when ethanol extracts of H.sabdariffa was administered for 26 days (1 g/kg per day) (Amin
and Hamza, 2006). The extract also revealed anti-mutagenic activity in vitro
against 1-nitropyrene, a potent mutagen (Olvera-Garcia et al., 2008) and reduction of micronuclei in polychromatic
erythrocytes (PCEs) (Adetutu, et al.,
2004). The administration of ethanolic H.sabdariffa
extracts (200 mg/kg and 300 mg/kg, orally) in rabbits over a period of eight
weeks did not show any toxic effect when dyslipidemia and oxidant stress
associated with prolonged excessive intake of cholesterol was studied in these
animals ( Ekor et al., 2010).
Based
on the data presented above, dosages up to 200 mg/kg should be safe and not
show signs of toxicity, but further studies, most importantly with chemically
well characterised extracts, are warranted.
1.1.7. Interactions
While
there is no particular ground for suspicion of a relevant interaction potential
of Hibiscus, several preclinical and one clinical study have addressed this
issue. The sub-acute effect of an aqueous cH.sabdariffa
extract on CYP450 activity, clinical blood chemistry and haematology was
investigated in male Wistar rats at 250 and 1000 mg/kg/day for 30 days. The authors
found no effect on hepatic phase I enzymes (CYP 1A1, 1A2, 2B1/2, 2E1 and 3A)
and the extract did not significantly affect blood chemistry and haematology.
(Prommett et al., 2006). More
recently, the interaction of a methanolic H.sabdariffa
flower extract and hydrochlorothiazide (a diuretic drug) was examined in adult
albino mice, albino rats and healthy adult rabbits. Co-administration of the
extract (20–40 mg/kg b.w.) with hydrochlorothiazide (10 mg/kg) caused a
significant increase in the volume of urine excreted, as well as a significant
decrease in the pH of urine and the concentrations of sodium, bicarbonate and
chloride ions. It also increased and prolonged the plasma concentration, the
mean area under the concentration–time curve and the volume of distribution of
the diuretic drug over a 24 h sampling period (Ndu et al., 2011). Regarding the type of preparation (methanol extract)
and mode of administration (intraperitoneal), the relevance of these findings
for the use of traditional hibiscus preparations remains highly questionable.
The
pharmacokinetics of chloroquine (600 mg) and a freshly prepared H.sabdariffa beverage, similar in taste
and concentration to the one usually consumed by Sudanese people, were studied
in healthy males. The study showed a statistically significant reduction in the
area under the plasma concentration versus time curve and the peak plasma
concentration of chloroquine (Mahmoud et
al., 1994). In view of the very small group size (N = 6) and the poor
information on the mode of preparation and dosage of the hibiscus beverage, the
results of this study need to be interpreted with caution.
The
effect of so-called Zobo Drink (sweetened aqueous extract prepared from 30 g
dried hibiscus calyces/l) on acetaminophen pharmacokinetics was studied in
healthy young men (N = 6, crossover design). No significant kinetic changes
were observed when the extract was administered concomitantly with
acetaminophen, except for a slight elevation of the clearance by Ca. 11%. Given
the poorly described study protocol and the small sample size of N = 6, the
conclusions of the authors on a possible interaction potential of hibiscus
should be read with caution (Kolawole and Maduenyi, 2004).
Taken
together, the data available today from preclinical and clinical studies does
not provide substantiated evidence of any therapeutically relevant interaction
potential of commonplace teas or beverages containing hibiscus and its
preparations. This complements the evidence based on the complete absence of drug
interaction case reports involving hibiscus in the scientific literature.
1.1.8. Anatomy of the
male rat testes
1.1.8.1. Brief anatomy
of the rat testes
Grossly,
the normal adult rat testis is a paired organ that lies within the scrotum
suspended by the spermatic cord. The average weight of each testis is 1–2g, the
right usually being 10% heavier than the left. The organ is covered by a
capsule composed of three layers: the outer serosa or tunica vaginalis (covered
by a flattened layer of mesothelial cells), the tunica albuginea, and the inner
tunica vasculosa. The posterior portion of the capsule, called the mediastinum,
contains blood and lymph vessels, nerves, and the mediastinal portion of the
rete testis.
Fig.5. Structure of male rat testes
Histologically,
The parenchyma is divided into approximately 250 lobules, each lobule
containing up to four seminiferous tubules The seminiferous tubules are bound
by a limiting membrane made up of basal lamina and alternating layers of cells
of Leydigand collagen fibers. These tubules contain germ cells in various
stages of development and Sertoli cells
Fig. 6: Spermatogenic series
1.1.8.2.
Structure-Function relationship of the male rat testes
Testes is the male gonad in rat
and other animals. Like the ovaries to which they are homologous, testes are
components of both the reproductive system and the endocrine system. The
primary functions of the testes are to produce sperm (spermatogenesis) and to
produce androgens, primarily testosterone.
Both functions of the testicle
are influenced by gonadotropic hormones produced by the anterior pituitary.
Luteinizing hormone (LH) results in testosterone release. The presence of both
testosterone and follicle-stimulating hormone (FSH) is needed to support
spermatogenesis. It has also been shown in
animal studies that if testes are exposed to either
too high or toolow levels of estrogens (such as estradiol ; E2) spermatogenesis
can be disrupted to such an extent that the animals become infertile.
Within the seminiferous tubules,
germ cells develop into spermatogonia, spermatocytes, spermatids and spermatozoon
through the process of spermatogenesis. The gametes contain DNA for
fertilization of an ovum.
Sertoli cells – the true
epithelium of the seminiferous epithelium, critical for the support of germ
cell development into spermatozoa. Sertoli cells secrete inhibin.
Peritubular myoid cells surround the seminiferous
tubules.
Between tubules (interstitial
cells), Leydig cells are localized between seminiferous tubules and they
produce and secrete testosterone and other androgens important for sexual
development and puberty, secondary sexual
Characteristics like facial
hair, sexual behavior and libido, supporting spermatogenesis and erectile
function. Testosterone also controls testicular volume. Also present are -
Immature Leydig cells, interstitial macrophages and epithelial cells.
The accessory glands of the male reproductive
system are the seminal vesicles, prostate gland, and the bulbourethral
glands.These glands secrete fluids that enter the urethra.
Seminal
Vesicles
The paired seminal vesicles are
saccular glands posterior to the urinary bladder. Each gland has a short duct
that joins with the ductus deferens at the ampulla to form an ejaculatory duct,
which then empties into the urethra. The fluid from the seminal vesicles is
viscous and contains fructose, which provides an energy source for the sperm;
prostaglandins, which contribute to the mobility and viability of the sperm;
and proteins that cause slight coagulation reactions in the semen after
ejaculation.
Prostate
The prostate gland is a firm,
dense structure that is located just inferior to the urinary bladder. It is
about the size of a walnut and encircles the urethra as it leaves the urinary
bladder. Numerous short ducts from the substance of the prostate gland empty
into the prostatic urethra. The secretions of the prostate are thin, milky colored,
and alkaline. They function to enhance the motility of the sperm.
Bulbourethral
Glands
The paired bulbourethral (Cowper's)
glands are small, about the size of a pea, and located near the base of the
penis. A short duct from each gland enters the proximal end of the penile
urethra. Inresponse to sexual stimulation, the bulbourethral glands secrete an
alkaline mucus-like fluid. This fluid neutralizes the acidity of the urine
residue in the urethra, helps to neutralize the acidity of sthe vagina, and
provides some lubrication for the tip of the penis during intercourse.
Seminal
Fluid
Seminal fluid, or semen, is a slightly alkaline
mixture of sperm cells and secretions from the accessory glands. Secretions
from the seminal vesicles make up about 60 percent of the volume of the semen,
with most of the remainder coming from the prostate gland. The sperm and
secretions from the bulbourethral gland contribute only a small volume.
1.1.9.
Reproductive hormones
1.1.9.1.
Follicle stimulating hormone (FSH)
Follicle-stimulating hormone (FSH)
is a glycoprotein hormone found in humans and other animals. It is synthesized
and secreted by gonadotropes of the anterior pituitary gland, and regulates the
development, growth, pubertal maturation, and reproductive processes of the
body. FSH and luteinizing hormone (LH) act synergistically in reproduction .FSH
is a 35.5 kDa glycoprotein heterodimer, consisting of two polypeptide units,
alpha and beta. The alpha subunits of the glycoproteins FSH consist of about 96
amino acids, while the beta subunit consists
of 111 amino acids (FSH β),which confers its specific biologic action, and is
responsible for interaction with the follicle-stimulating hormone receptor(Jang
et al., 2012) .In males, FSH induces
Sertoli cells to secrete androgen- binding proteins (ABPs), regulated by
inhibin 's negative feedback mechanism on the anterior pituitary .
In females, FSH initiates follicular growth,
specifically affecting granulosa cells .GnRH has been shown to play an
important role in the secretion of FSH, with hypothalamic-pituitary disconnection
leading to a cessation of FSH. GnRH administration leads to a return of FSH
secretion.
FSH is subject to oestrogen
feed-back from the gonads via the hypothalamic pituitary gonadal axis. FSH
stimulates the growth and recruitment of immature ovarian follicles in the
ovary. In early (small) antral follicles, FSH is the major survival factor that
rescues the small antral follicles (2– 5 mm in diameter for humans) from
apoptosis (programmed death of the somatic cells of the follicle and oocyte).
In the luteal-follicle phase transition period the serum levels of progesterone
and estrogen (primarily estradiol) decrease and no longer suppress the release
of FSH, consequently FSH peaks at about day three (day one is the first day of
menstrual flow). The cohort of small antral follicles is normally sufficiently
in number to produce enough Inhibin B to lower FSH serum levels.
In addition, there is evidence
that gonadotrophin surge-attenuating factor produced by small follicles during
the first halfof the follicle phase also exerts anegative feedback on pulsatile
luteinizing hormone (LH) secretion amplitude, thus allowing a more favorable
environment for follicle growth and preventing
premature luteinization (Fowler et al., 2003). As a woman nears
perimenopause, the number of small antral follicles recruited in each cycle
diminishes and consequently insufficient Inhibin B is produced to fully lower
FSH and the serum level of FSH begins to rise. Eventually the FSH level becomes
so high that downregulation of FSH receptors occurs and by postmenopause any
remaining small secondary follicles no longer have FSH nor LH receptors
(Vihkko, 1996).
When the follicle matures and
reaches 8–10 mm in diameter it starts to secrete significant amounts of
estradiol. Normally in humans only one follicle becomes dominant and survives
to grow to 18–30 mm in size and ovulate, the remaining follicles in the cohort
undergo atresia. The sharp increase in estradiol production by the dominant follicle
(possibly along with a decrease in gonadotrophin surge-attenuating factor)
cause a positive effect on the hypothalamus and pituitary and rapid GnRH pulses
occur and an LH surge results.
The increase in serum estradiol
levels cause a decrease in FSH production by inhibiting GnRH production in the
hypothalamus (Dickerson et al., 2008).
The decrease in serum FSH level causes the smaller follicles in the current
cohort to undergo atresia as they lack sufficient sensitivity to FSH to
survive. Occasionally two follicles reach the
10 mm stage at the same time by
chance and as both areequally sensitive to FSH both survive and grow in the low
FSH environment and thus two ovulations can occur in one cycle possibly leading
to non-identical (dizygotic ) twins.
FSH stimulates primary spermatocytes
to undergo the first division of meiosis, to form secondary spermatocytes.
FSH enhances the production of androgen-binding
protein by the Sertoli cells of the testes by binding to FSH receptors on their
basolateral membranes, and is critical for the initiation of spermatogenesis
(Boulpaep and boron, 2005).
1.1.9.2.
Luteinizing hormone (LH)
Luteinizing hormone (LH), also
known as lutropin and sometimes lutrophin (Ujihara et al., 1992) is a hormone produced by gonadotropic cells in the anterior
pituitary gland. In females, an acute rise of LH (" LH surge")
triggers ovulation and development of the corpus luteum. In males, where LH had
also been called interstitial cell- stimulating hormone (ICSH ), it stimulates
Leydig cell production of testosterone. It acts synergistically with FSH
(louvet et al., 1975).
LH is a hetero dimeric glycoprotein.
Each monomeric unit is a glycoprotein molecule; one alpha and one beta subunit
make the full, functional protein. Its structure is similar to that of the
other glycoproteinhormones, follicle-stimulating hormone (FSH), thyroid-
stimulating hormone (TSH), and human chorionic gonadotropin (hCG). The protein
dimer contains 2 glycopeptidic subunits, alpha and beta subunits, that are
non-covalently associated (Jiang et al.,
2014). The alpha subunits of LH, contain 92 amino acids in human but 96 amino acids
in almost all other vertebrate species.
The beta subunits vary. LH has a beta subunit of 120 amino acids (LHB)
that confers its specific biologic action and is responsible for the
specificity of the interaction with the LH receptor. The biologic half-life of
LH is 20 minutes, shorter than that of FSH (3–4 hours).
LH supports theca cells in the
ovaries that provide androgens and hormonal precursors for estradiol
production. At the time of menstruation, FSH initiates follicular growth,
specifically affecting granulosa cells (Bowen, 2004). With the rise in estrogens, LH receptors are
also expressed on the maturing follicle, which causes it to produce more
estradiol. Eventually, when the follicle has fully matured, a spike in
17-hydroxyprogesterone production by the follicle inhibits the production of
estrogens, leading to a decrease in estrogen-mediated negative feedback of GnRH
in the hypothalamus, which then stimulates the release of LH from the anterior
pituitary (Mahesh, 2011). LH is
necessary to maintain luteal function for the first two weeks of the menstrual
cycle. If pregnancy occurs, LH levels will decrease, and luteal function will
instead be maintained by the action of hCG (humanchorionic gonadotropin), a
hormone very similar to LH but secreted from the new placenta. LH acts upon the
Leydig cells of the testis and is regulated by GnRH. The Leydig cells produce
testosterone (T) under the control of LH, which regulates the expression of the
enzyme 17- β hydroxysteroid dehydrogenase that is used to convert
androstenedione, the hormone produced by the gonads, to testosterone, an
androgen that exerts both endocrine activity and intratesticular activity on
spermatogenesis.
LH is released from the
pituitary gland, and is controlled by pulses of gonadotropin-releasing hormone
(GnRH). When T levels are low, GnRH is released by the hypothalamus,
stimulating the pituitary gland to release LH. As the levels of T increase, it
will act on the hypothalamus and pituitary through a negative feedback loop and
inhibit the release of GnRH and LH consequently. Androgens (T, DHT) inhibit
monoamine oxidase (MOA) in pineal, leading to increased melatonin and reduced
LH and FSH by melatonin-induced increase of GnIH synthesis and secretion.
1.1.9.3. Testosterone
Testosterone is a steroid hormone
from the androgen group and is found in humans and other vertebrates. In humans
and other mammals, testosterone is secreted primarily by the testicles ofmales
and, to a lesser extent, the ovaries of females. Small amounts are also
secreted by the adrenal glands. It is the principal male sex hormone and an
anabolic steroid .
In men, testosterone plays a key
role in the development of male reproductive tissues such as the testis and
prostate as well as promoting secondary sexual characteristics such as
increased muscle, bone mass, and the growth of body hair . In addition, testosterone is essential for
health and well-being (Bassil et al.,
2009) as well as the prevention of osteoporosis (Tuck and Francis, 2009).
On average, in adult males,
levels of testosterone are about 7–8 times as great as in adult females
(Torjesen and sandnes, 2004). As the
metabolic consumption of testosterone in males is greater, the daily production
is about 20 times greater in men (Southren et
al., 1967).Females are also more sensitive to the hormone (Dabbs and Dabbs,
2000).Testosterone is observed in most vertebrates.
Testosterone is necessary for
normal sperm development. It activates genes in Sertoli cells, which promote differentiation
of spermatogonia. Regulates acute HPA (Hypothalamic–pituitary–adrenal axis) response
under dominance challenge, Regulator of cognitive and physical energy, Maintenance
of muscle trophism.
Testosterone regulates the
population of thromboxane A 2receptors on megakaryocytes and platelets and
hence platelet aggregation in humans.
High androgen levels are associated
with menstrual cycle irregularities in both clinical populations and healthy
women.
Testosterone does not cause deleterious
effects in prostate cancer. In people who have undergone testosterone
deprivation therapy, testosterone increases beyond the castrate level have been
shown to increase the rate of spread of an existing prostate cancer.
Recent studies have shown conflicting
results concerning the importance of testosterone in maintaining cardiovascular
health.
Nevertheless, maintaining normal
testosterone levels in elderly men has been shown to improve many parameters
that are thought to reduce cardiovascular disease risk, such as increased lean
body mass, decreased visceral fat mass, decreased total cholesterol, and
glycemic control.
1.1.9.4. Estradiol
Estradiol, or more precisely, 17β-estradiol,
is a steroid and estrogen sex hormone, and the primary female sex hormone. Itis
named for and is important in the regulation of the estrous and menstrual
female reproductive cycles. Estradiol is essential for the development and maintenance
of female reproductive tissues (Ryan, 1982) but it also has important effects
in many other tissues including bone. While estrogen levels in men are lower compared
to women, estrogens have essential functions in men as well. Estradiol is found
in most vertebrates as well as many crustaceans, insects, fish, and other
animal species (Ozon, 1972).
Estradiol derives from estra,
literally meaning "verve or inspiration") and -diol , a chemical name
and suffix indicating that this form of steroid and sex hormone is a type of alcohol
bearing two hydroxyl groups .
Estradiol is produced especially
within the follicles of the female ovaries, but also in other endocrine (i.e.,
hormone-producing) and non-endocrine tissues (e.g., including fat, liver,
adrenal, breast, and neural tissues). Estradiol is biosynthesized from progesterone
(Saldanha et al., 2011).
In the female, estradiol acts as
a growth hormone for tissue of the reproductive organs, supporting the lining
of the vagina, the cervical glands, the endometrium, and the lining of the
fallopian tubes. It enhances growth of the myometrium. Estradiol appears necessary
to maintain oocytes in the ovary. During the menstrual cycle, estradiol produced
by the growing follicle triggers, via a positive feedback system, the
hypothalamic-pituitary events that lead to the luteinizing hormone
surge,inducing ovulation. In the luteal phase, estradiol, in conjunction with
progesterone, prepares the endometrium for implantation.
During pregnancy, estradiol
increases due to placental production. In baboons, blocking of estrogen
production leads to pregnancy loss, suggesting estradiol has a role in the maintenance
of pregnancy.
The development of secondary sex
characteristics in women is driven by estrogens, to be specific, estradiol.
These changes are initiated at the time of puberty, most are enhanced during
the reproductive years, and become less pronounced with declining estradiol
support after the menopause. Thus, estradiol produces breast development, and
is responsible for changes in the body shape, affecting bones, joints, and fat
deposition. Fat structures and skin composition are modified by estradiol. The effect of estradiol (and estrogens in
general) upon male reproduction is complex. Estradiol is produced by action of aromatase
mainly in the Leydig cells of the mammalian testis, but also by some germ cells
and the Sertoli cells of immature mammals (Carreaus et al., 2003). It functions
(in vitro) to prevent apoptosis of male sperm cells (Pentikainen et al., 2000).
Several studies have noted sperm counts have been
declining in many parts of the world, and estrogen exposure in the environment
has been postulated to be the cause (Sharpe and Skakkebaek, 1993).
Suppression of estradiol production in a
subpopulation ofsubfertile men may improve the semen analysis (Raman and
Schlegel, 2002).
Males with certain sex chromosome genetic
conditions, such as Klinefelter's syndrome, will have a higher level of
estradiol (Visootsak and Graham, 2006).
1.1.9.5 Prolactin
Prolactin (PRL), also known as
luteotropic hormone or luteotropin, is a protein that in humans is best known
for its role in enabling female mammals to produce milk; however, it is
influential over a large number of functions with over 300 separate actions of
PRL having been reported in various vertebrates (Bole-Feysot, et al., 1998). Prolactin is secreted
from the pituitary gland in response to eating, mating, estrogen treatment,
ovulation, and nursing. Prolactin is secreted in a pulsatile fashion in between
these events. Prolactin also plays an essential role in metabolism, regulation
of the immune system, and pancreatic development. Prolactin is a Peptide hormone,
encoded by the PRL gene. Although often associated with human milk production,
prolactin plays a wide range of other roles in both humans and other vertebrates.
(For example, in fish—the oldest known vertebrates — an important function is
probably related to control of water andsalt balance.Prolactin also acts in a
cytokine -like manner and as an important regulator of the immune system. It
has important cell cycle related functions as a growth-, differentiating- and
anti- apoptotic factor. As a growth factor, binding to cytokine like receptors,
it also has profound influence on hematopoiesis, angiogenesis and is involved
in the regulation of blood clotting through several pathways. The hormone acts
in endocrine, autocrine, and paracrine manner through the prolactin receptor
and a large number of cytokine receptors.
Prolactin has a wide range of
effects. It stimulates the mammary glands to produce milk (lactation):
increased serum concentrations of prolactin during pregnancy cause enlargement
of the mammary glands of the breasts and prepare for the production of milk.
Milk production normally starts when the levels of progesterone fall by the end
of pregnancy and a suckling stimulus is present.
Sometimes, newborn babies (males
as well as females) secrete a milky substance from their nipples known as
witch's milk. This is in part caused by maternal prolactin and other hormones.
Prolactin also has been found to play an important role in maternal behavior (lucas
et al., 1998).
Prolactin provides the body with
sexual gratification after sexual acts: The hormone counteracts the effect of
dopamine, which is responsible for sexual arousal. This is thought to cause the
sexual refractory period. The amount of prolactin can be an indicator forthe
amount of sexual satisfaction and relaxation. Unusually high amounts are
suspected to be responsible for impotence and loss of libido.
Prolactin within the normal reference ranges can
act as a weak gonadotropin but at the same time suppresses GnRH secretion.
The exact mechanism by which it inhibits GnRH is
poorly understood although expression of prolactin receptors (PRL-R) have been
demonstrated in rat's hypothalamus, the same has not been observed in GnRH
neurons (Grattan et al., 2007). Physiologic
levels of prolactin in males enhance luteinizing hormone -receptors in Leydig
cells, resulting in testosterone secretion, which leads to spermatogenesis
(Hair et al., 2002).
Prolactin also stimulates proliferation of oligodendrocyte
precursor cells. These cells differentiate into oligodendrocytes, the cellsresponsible
for the formation of myelin coatings on axons in thecentral nervous system
(Gregg et al., 2007).
Prolactin promotes neurogenesis in maternal and
fetal brains (Larsen and Grattan, 2012).
Prolactin delays hair regrowth in mice (Craven et al., 2006)
Login To Comment